Literature DB >> 17675316

Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis.

P M Gustafsson1, P A De Jong, H A W M Tiddens, A Lindblad.   

Abstract

BACKGROUND: A sensitive and valid non-invasive marker of early cystic fibrosis (CF) lung disease is sought. The lung clearance index (LCI) from multiple-breath washout (MBW) is known to detect abnormal lung function more readily than spirometry in children and teenagers with CF, but its relationship to structural lung abnormalities is unknown. A study was undertaken to determine the agreements between LCI and spirometry, respectively, with structural lung disease as measured by high-resolution computed tomography (HRCT) in children and teenagers with CF.
METHODS: A retrospective study was performed in 44 consecutive patients with CF aged 5-19 years (mean 12 years). At an annual check-up inspiratory and expiratory HRCT scans, LCI and spirometric parameters (forced expiratory volume in 1 s (FEV1) and maximal expiratory flow when 75% of forced vital capacity was expired (FEF75)) were recorded. Abnormal structure was defined as a composite HRCT score of >5%, the presence of bronchiectasis or air trapping >30%. Abnormal lung function was defined as LCI above the predicted mean +1.96 residual standard deviations (RSD), or FEV1 or FEF75 below the predicted mean -1.96 RSD. Sensitivity/specificity assessments and correlation analyses were done.
RESULTS: The sensitivity to detect abnormal lung structure was 85-94% for LCI, 19-26% for FEV1 and 62-75% for FEF75. Specificity was 43-65% for LCI, 89-100% for FEV1 and 75-88% for FEF75. LCI correlated better with HRCT scores (Rs +0.85) than FEV1 (-0.62) or FEF75 (-0.66).
CONCLUSIONS: LCI is a more sensitive indicator than FEV1 or FEF75 for detecting structural lung disease in CF, and a normal LCI almost excludes HRCT abnormalities. The finding of an abnormal LCI in some patients with normal HRCT scans suggests that LCI may be even more sensitive than HRCT scanning for detecting lung involvement in CF.

Entities:  

Mesh:

Year:  2007        PMID: 17675316     DOI: 10.1136/thx.2007.077784

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  74 in total

Review 1.  Management of severe asthma in children.

Authors:  Andrew Bush; Sejal Saglani
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

2.  Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls.

Authors:  BreAnna Kinghorn; Sharon McNamara; Alan Genatossio; Erin Sullivan; Molly Siegel; Irma Bauer; Charles Clem; Robin C Johnson; Miriam Davis; Anne Griffiths; William Wheeler; Katherine Johnson; Stephanie D Davis; Margaret W Leigh; Margaret Rosenfeld; Jessica Pittman
Journal:  Ann Am Thorac Soc       Date:  2020-09

Review 3.  Chest imaging in cystic fibrosis studies: What counts, and can be counted?

Authors:  Rhonda Szczesniak; Lidija Turkovic; Eleni-Rosalina Andrinopoulou; Harm A W M Tiddens
Journal:  J Cyst Fibros       Date:  2016-12-28       Impact factor: 5.482

4.  Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis.

Authors:  Don B Sanders; Zhanhai Li; Alan S Brody; Philip M Farrell
Journal:  Am J Respir Crit Care Med       Date:  2011-10-01       Impact factor: 21.405

5.  New time-saving predictor algorithm for multiple breath washout in adolescents.

Authors:  Jonathan Grønbæk; Henrik Wegener Hallas; Lambang Arianto; Knud Pedersen; Arne Thomsen; Bo Lund Chawes; Hans Bisgaard
Journal:  Pediatr Res       Date:  2016-03-22       Impact factor: 3.756

6.  Use of lung clearance index to assess the response to intravenous treatment in cystic fibrosis.

Authors:  E Hatziagorou; V Avramidou; F Kirvassilis; J Tsanakas
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

7.  Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry.

Authors:  Laura L Walkup; Kasiani Myers; Javier El-Bietar; Adam Nelson; Matthew M Willmering; Michael Grimley; Stella M Davies; Christopher Towe; Jason C Woods
Journal:  Eur Respir J       Date:  2019-05-02       Impact factor: 16.671

Review 8.  The Evolution of Cystic Fibrosis Care.

Authors:  Jessica E Pittman; Thomas W Ferkol
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

Review 9.  Background and Epidemiology.

Authors:  Don B Sanders; Aliza K Fink
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

Review 10.  Functional imaging of the lungs with gas agents.

Authors:  Stanley J Kruger; Scott K Nagle; Marcus J Couch; Yoshiharu Ohno; Mitchell Albert; Sean B Fain
Journal:  J Magn Reson Imaging       Date:  2015-07-27       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.